Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.52 USD | -1.03% | +3.52% | -24.34% |
04-23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
04-22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.34% | 8.37B | |
+3.12% | 106B | |
+7.71% | 23.47B | |
-14.98% | 21.9B | |
-6.17% | 18.77B | |
-37.26% | 17.85B | |
-8.21% | 16.78B | |
+7.89% | 14.41B | |
+38.45% | 12.86B | |
+316.58% | 8.78B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Files Mixed-Securities Shelf Registration